SCHEMBL22157019

SCHEMBL22157019

N#Cc1cc(-n2c3ccccc3c3cc(-c4ncccn4)ccc32)c(-n2c3ccccc3c3cc(-c4ncccn4)ccc32)cc1-c1c(F)c(F)c(F)c(F)c1F

nearest known ligand 0.35

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CYP11B2 P19099 2/20 0.33
CYP11B1 P15538 1/20 0.33
ADORA2B P29275 1/20 0.33
CLK4 Q9HAZ1 1/20 0.33
NR3C1 P04150 1/20 0.32
HTR1A P08908 1/20 0.32
DRD4 P21917 1/20 0.32
HTR1B P28222 1/20 0.32
DRD3 P35462 1/20 0.32
CNR2 P34972 4/20 0.31
NPY5R Q15761 1/20 0.31
PDE4A P27815 1/20 0.31
PDE4C Q08493 1/20 0.31
PDE4D Q08499 1/20 0.31
CNR1 P21554 1/20 0.31
SQOR Q9Y6N5 1/20 0.31
AR P10275 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22157196 0.96 CLK4 (0.35) CYP11B2CYP11B1ADORA2BCLK4NR3C1
SCHEMBL22156388 0.94 CYP11B2 (0.33) CYP11B2CYP11B1ADORA2BCLK4NR3C1
SCHEMBL22157021 0.94 CYP11B2 (0.33) CYP11B2CYP11B1ADORA2BCLK4NR3C1
SCHEMBL22156570 0.91 CYP11B2 (0.35) CYP11B2CYP11B1ADORA2BCLK4NR3C1
SCHEMBL22158302 0.90 CLK4 (0.35) CYP11B2CYP11B1ADORA2BCLK4NR3C1
SCHEMBL22157122 0.90 CYP11B1 (0.33) CYP11B2CYP11B1CLK4NR3C1CNR2
SCHEMBL22157204 0.89 CLK4 (0.35) CYP11B2CYP11B1ADORA2BCLK4NR3C1
SCHEMBL22158505 0.88 SSTR2 (0.36) CYP11B2CYP11B1CLK4NR3C1HTR1A
SCHEMBL22156387 0.88 CYP11B2 (0.33) CYP11B2CYP11B1ADORA2BCLK4NR3C1
SCHEMBL22156577 0.87 CYP11B1 (0.36) CYP11B2CYP11B1NR3C1CNR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200203628-A1 ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2020-06-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200203628-A1 ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES OR10J3, ORC3, OR51E2 CYP11B2 531/4885CYP11B1 827/4885ADORA2B 3901/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.